Radiation therapy can and frequently does cause scar tissue, a condition doctors call radiation-induced fibrosis. When high-energy beams target a tumor, they also damage nearby healthy cells, and the body’s repair process sometimes overshoots, laying down dense, stiff collagen where supple tissue used to be. This fibrosis can show up in virtually any irradiated organ, from skin and muscle to lungs, heart, and brain, and it can appear months or even years after treatment ends. The process is driven largely by overactive repair cells that keep producing structural protein long after the original injury has healed.
How Radiation Triggers Excess Scar Tissue
Under normal circumstances, when your body repairs a wound it sends in specialized cells called fibroblasts that produce collagen and other structural materials to patch things up. Once healing is complete, those cells quiet down. Radiation disrupts that off switch. The energy damages DNA and cell membranes in the treatment zone, which kicks off an inflammatory cascade. One of the most important chemical signals released during this cascade is a growth factor called TGF-β, which tells fibroblasts to transform into a more aggressive form known as myofibroblasts. These myofibroblasts churn out collagen at a much higher rate than ordinary repair cells.1PubMed Central. Tissue fibrosis induced by radiotherapy: current understanding of the molecular mechanisms, diagnosis and therapeutic advances
The problem is that in radiation-damaged tissue, TGF-β signaling doesn’t switch off on schedule. Fibroblasts stay activated, and the extracellular matrix, the scaffolding between cells, keeps thickening. The result is a patch of tissue that is denser, stiffer, and less functional than what was there before. Think of it as a wound-healing program stuck in a loop: the body keeps reinforcing a repair job that was finished long ago.
This process typically unfolds in two stages. First, within days to weeks after treatment, there’s an acute inflammatory reaction with swelling, redness, and sometimes skin peeling. In most patients this settles down. But beneath the surface, the fibrotic machinery may already be running. The late-phase fibrosis usually becomes clinically noticeable anywhere from several months to a few years after radiotherapy ends, and once established it tends to be permanent and can even progress over time.
Where in the Body Fibrosis Shows Up
Because radiation can be aimed at almost any part of the body, fibrosis can develop in a wide range of tissues. The specific symptoms depend entirely on what was in the treatment field.
Skin and Soft Tissue
Skin is the most visible site. Chronic radiation changes to skin include thinning, stiffness, and loss of hair in the treated area.2PubMed Central. Radiation-Induced Skin Fibrosis: Pathogenesis, Current Treatment Options, and Emerging Therapeutics The skin may feel leathery or woody, and it can become permanently discolored. Underlying muscle and connective tissue can stiffen as well, restricting range of motion. In breast cancer patients who’ve had implant-based reconstruction, the scar capsule that naturally forms around the implant can tighten dramatically after radiation. One study found that about one in five women who received chest wall radiotherapy after implant reconstruction developed severe capsular contracture requiring additional surgery, compared with none in the unirradiated group.3PubMed. Incidence of severe capsular contracture following implant-based immediate breast reconstruction with or without postoperative chest wall radiotherapy using 40 Gray in 15 fractions Molecular analysis of the irradiated capsule tissue has confirmed significantly elevated markers of fibrotic activity compared with non-irradiated capsules.4PubMed Central. Thy1 (CD90) expression is elevated in radiation-induced periprosthetic capsular contracture: implication for novel therapeutics
Lungs
Radiation-induced lung injury is one of the best-studied examples. It typically unfolds as radiation pneumonitis, an acute inflammation occurring roughly six to twelve weeks after treatment, followed over the next six to twelve months by gradual progression to permanent lung fibrosis.5PubMed. Pulmonary effects of radiation therapy Patients may notice a dry cough, shortness of breath, or reduced exercise tolerance. The scarred lung tissue simply cannot exchange oxygen as efficiently as healthy tissue. In milder cases, the fibrosis is limited to the area directly in the radiation field and causes few symptoms. In severe cases, it can meaningfully impair breathing.6PubMed Central. Radiation-Induced Lung Injury: Assessment and Management
Head and Neck
Fibrosis in the head and neck region can be particularly disruptive to everyday life. Scar tissue forming in the jaw muscles leads to a condition called trismus, where the mouth progressively loses its ability to open fully. This makes eating, speaking, and dental care difficult, and it complicates follow-up examinations for cancer recurrence.7PubMed Central. Unforeseen Outcomes Post Treatment for Radiation Induced Trismus: A Case Report Beyond the jaw, fibrosis of the throat muscles, salivary glands, and surrounding soft tissues contributes to swallowing dysfunction, chronic dry mouth, and nerve damage.8PubMed. Radiation-induced swallowing dysfunction in patients with head and neck cancer: A literature review The molecular mechanism behind radiation-induced trismus follows the same TGF-β-driven fibrotic pathway seen elsewhere in the body.9PubMed Central. Etiopathogenesis of Trismus in Patients With Head and Neck Cancer: An Exploratory Literature Review
Heart
Fibrosis is a central feature of radiation-induced heart disease. Radiation can cause scarring across every component of the heart, including the heart muscle itself, the coronary arteries, the valves, and the outer lining.10PubMed Central. Radiation-Induced Cardiovascular Disease: Review of an Underrecognized Pathology This scarring can translate into cardiomyopathy, accelerated coronary artery disease, valve dysfunction, and irregular heart rhythms.11PubMed Central. Radiation-induced heart disease: pathologic abnormalities and putative mechanisms These effects are most relevant for patients treated with chest radiation for cancers like Hodgkin lymphoma or left-sided breast cancer, where the heart sits close to the treatment field. Cardiac problems may not emerge until a decade or more after treatment, which is why long-term cardiac monitoring is part of survivorship care for these patients.
Brain
In the brain, extreme cases of radiation damage produce areas of tissue death surrounded by a “glial scar,” a ring of reactive support cells that wall off the dead zone. Animal studies using high radiation doses show that this necrosis and scarring is accompanied by significant inflammation, including activated immune cells and buildup of structural scar-like tissue around the damaged area.12PubMed Central. Radionecrosis and cellular changes in small volume stereotactic brain radiosurgery in a porcine model In clinical practice, radiation necrosis is less common than in these experimental models, but it remains a recognized late complication of brain radiotherapy.
Why Some People Develop Worse Fibrosis Than Others
Not everyone who receives the same radiation dose to the same body part develops the same degree of scarring. There is well-documented variability between patients, and genetics appears to play a substantial role. Some people carry gene variants that make their fibroblasts more prone to overactivation, or their inflammatory response slower to resolve.13PubMed. Genetic susceptibility to late normal tissue injury Identifying those specific genes has proven difficult because fibrosis is a complex trait influenced by many genes at once, not a single-gene disorder.14PubMed Central. Radiation Fibrosis Syndrome: the Evergreen Menace of Radiation Therapy
Beyond genetics, several other factors influence risk. Higher total radiation doses and larger treatment volumes expose more healthy tissue to damage. Concurrent chemotherapy can amplify the injury. Certain pre-existing conditions, including connective tissue disorders and diabetes, can impair healing and promote scarring. And the inherent sensitivity of the organ matters: some tissues, such as lung and liver, are more fibrosis-prone than others.
Animal research has given a window into just how variable the fibrotic response can be. In one study, two strains of mice given the same skin radiation showed similar acute reactions, but months later one strain developed significantly worse scarring and limb contracture. The strain with worse outcomes had higher TGF-β levels in the skin at every time point measured, reinforcing the link between that signaling molecule and long-term fibrosis severity.15PubMed Central. Radiation-induced skin injury in the animal model of scleroderma: implications for post-radiotherapy fibrosis
Telling Scar Tissue Apart from Cancer Recurrence
One of the trickiest clinical problems after radiation therapy is figuring out whether a lump or abnormality on imaging is harmless scar tissue or a tumor coming back. Both can look similar on a standard CT or MRI scan. Doctors rely on advanced imaging tools to make the distinction. In the brain, specialized MRI sequences measuring blood flow and metabolic activity can help separate radiation necrosis from active tumor.16PubMed. Radiation necrosis in the brain: imaging features and differentiation from tumor recurrence
In the pelvis, particularly after rectal cancer treatment, PET scans that measure sugar metabolism have proven useful. Cancer cells are metabolically hungry and light up brightly on PET, while scar tissue does not. One study found that recurrent rectal tumors accumulated the PET tracer at roughly five times the rate of scar tissue, and combining PET with MRI improved the accuracy of the diagnosis beyond what either test could achieve alone.17PubMed. Recurrent rectal cancer and scar: differentiation with PET and MR imaging When imaging is ambiguous, biopsy remains the definitive answer, but the goal of these techniques is to spare patients from unnecessary invasive procedures.
Do Modern Radiation Techniques Prevent Fibrosis?
Radiation technology has improved dramatically over the past few decades. Techniques like intensity-modulated radiation therapy (IMRT), stereotactic body radiotherapy, and image-guided radiotherapy allow doctors to sculpt the radiation beam much more precisely around the tumor, reducing the dose that spills into surrounding healthy tissue. These advances have lowered the rate of acute side effects. However, fibrosis remains a common complication even with these newer approaches.18PubMed. Exploring radiation-induced fibrosis: biological mechanisms and new frontiers in research and therapeutics The reason is straightforward: some healthy tissue almost always falls within the treatment field, and even moderate doses can trigger the fibrotic cascade in susceptible individuals. Better targeting helps, but it hasn’t eliminated the problem.
Treatment and Management Options
Once established, radiation fibrosis is difficult to reverse, but several strategies can slow its progression or partially reduce it.
Medications
The best-studied drug combination is pentoxifylline, a blood-flow-enhancing medication, paired with vitamin E, an antioxidant. In a randomized, placebo-controlled trial, the combination produced significantly greater regression of superficial fibrosis compared with placebo, with treated patients seeing roughly 60% shrinkage of the affected area on average versus about 43% with placebo.19PubMed. Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis The regimen is generally well tolerated and has been studied as a preventive strategy as well.20PubMed Central. Pentoxifylline and vitamin E drug compliance after adjuvant breast radiation therapy It’s not a cure, but it’s one of the few interventions with solid clinical trial evidence behind it.
Hyperbaric Oxygen
Hyperbaric oxygen therapy, which involves breathing pure oxygen inside a pressurized chamber, has been proposed for late radiation tissue injury. The idea is that flooding damaged tissue with oxygen can stimulate new blood vessel growth and improve healing. A systematic review found evidence of benefit for radiation-related proctitis and soft tissue wounds in the head and neck, though it did not show clear benefit for conditions like radiation cystitis or soft tissue swelling.21PubMed. Systematic review of hyperbaric oxygen therapy for the treatment of non-neurological soft tissue radiation-related injuries Access can be limited and sessions are time-consuming, so it tends to be reserved for cases where other treatments haven’t worked.
Physical Therapy and Massage
Physical rehabilitation plays an important role, especially for fibrosis that restricts movement. For head and neck patients with trismus, jaw-stretching exercises and devices can help maintain or recover mouth opening. For chest and breast fibrosis, deep friction massage techniques have shown promise in breaking down fibrotic tissue, relieving painful muscle spasms, and improving mobility in the chest wall.22PubMed Central. Deep Friction Massage in Treatment of Radiation-induced Fibrosis: Rehabilitative Care for Breast Cancer Survivors Starting rehabilitation early, before fibrosis becomes severe, is generally more effective than trying to reverse advanced scarring.
Children Face Unique Long-Term Risks
Radiation-induced fibrosis is a particular concern in pediatric patients, whose tissues are still growing. In a study of children treated with radiotherapy for extremity sarcomas, fibrosis was found in 80% of patients during long-term follow-up, alongside muscle wasting, bone growth abnormalities, and functional impairment.23PubMed. Late effects of radiotherapy for pediatric extremity sarcomas
Animal research modeling pediatric radiation has helped explain why these effects are so persistent. Mice given radiation at a young age showed lasting muscle fibrosis, reduced muscle mass, and fewer stem cells available for repair. These deficits didn’t resolve with time; when the mice were examined in middle age, muscle wasting and fibrotic gene activity were still present, along with ongoing inflammatory signaling.24PubMed Central. Muscle-specific functional deficits and lifelong fibrosis in response to paediatric radiotherapy and tumour elimination The implication for human patients is sobering: a child treated with radiation may carry the fibrotic burden for the rest of their life, and it can worsen as they age. This is one reason pediatric oncologists increasingly use proton therapy and other precision techniques to minimize the dose to growing tissues whenever possible.
Emerging Research and Future Therapies
Because existing treatments can slow but rarely fully reverse radiation fibrosis, there is active research into new approaches. A growing pool of experimental agents targets different steps in the fibrotic cascade, from blocking TGF-β signaling to modulating the immune response that drives collagen deposition. Some of the most interesting work involves combining anti-fibrotic strategies with immunotherapy. An early-stage study of a dual-action antibody designed to block both TGF-β and PD-L1 found that the agent could reduce radiation-induced fibrosis in the lungs and around treated tumors while simultaneously boosting anti-tumor immune responses.18PubMed. Exploring radiation-induced fibrosis: biological mechanisms and new frontiers in research and therapeutics If these dual-purpose drugs hold up in larger studies, they could offer cancer patients the benefit of radiation without as much collateral scarring.
Researchers are also working on better ways to predict who will develop severe fibrosis before treatment begins. If clinicians could identify high-risk patients through genetic testing or blood biomarkers, they could adjust radiation plans, offer preventive medications, or choose alternative treatments proactively. Objective methods of measuring fibrosis severity are another area of development; most current assessments rely on a clinician’s subjective feel of tissue stiffness, and standardized, reproducible tools would help both clinical care and research.25International Journal of Surgery Protocols. Radiation-induced fibrosis in breast cancer: A protocol for an observational cross-sectional pilot study for personalised risk estimation and objective assessment None of these innovations are ready for routine use yet, but they represent a shift from treating fibrosis after the fact toward anticipating and preventing it.
Living with Radiation Fibrosis
For many cancer survivors, radiation fibrosis is a chronic condition that requires ongoing management rather than a one-time fix. The psychological toll can be significant. Skin that looks or feels different, a jaw that won’t open, a shoulder that won’t raise to full height, or shortness of breath during exercise all affect how people feel about their bodies and what activities they can enjoy. These quality-of-life impacts deserve attention in survivorship planning, not just the physical measurements of tissue stiffness.
Practically speaking, staying ahead of fibrosis is easier than trying to reverse it later. Patients who know they’ve received radiation to a particular area should be attentive to progressive stiffness, tightness, or loss of range of motion and raise those changes with their care team early. Regular stretching and physical activity in the affected area, while it won’t prevent fibrosis entirely, can help maintain function. For those already dealing with established fibrosis, multidisciplinary rehabilitation teams that combine physical therapy, occupational therapy, and pain management tend to produce better outcomes than any single intervention alone.